Christophe Thuaire

Safety of the oral factor XIa inhibitor asundexian compared with apixaban in patients with atrial fibrillation (PACIFIC-AF): a multicentre, randomised, double-blind, double-dummy, dose-finding phase 2 study

Jonathan P. Piccini, Valeria Caso, Stuart J. Connolly et al. · The Lancet · 2022 · 311 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +11

Hospital admissions for acute myocardial infarction before and after lockdown according to regional prevalence of COVID-19 and patient profile in France: a registry study

Jules Mesnier, Yves Cottin, Pierre Coste et al. · The Lancet Public Health · 2020 · 208 citations · Full text

Medicine, Cardiology, Internal Medicine +11

DECOPI (DEsobstruction COronaire en Post-Infarctus): a randomized multi-centre trial of occluded artery angioplasty after acute myocardial infarction

Philippe Gabríel Steg, Christophe Thuaire, D. Himbert et al. · European Heart Journal · 2004 · 166 citations

Medicine, Cardiology, Cardiothoracic Surgery +10

Survival After Invasive or Conservative Management of Stable Coronary Disease

Judith S. Hochman, Rebecca Anthopolos, Harmony R. Reynolds et al. · Circulation · 2022 · 147 citations · Full text

Medicine, Cardiology, Internal Medicine +13

Beta-Blocker Interruption or Continuation after Myocardial Infarction

Johanne Silvain, Guillaume Cayla, Émile Ferrari et al. · New England Journal of Medicine · 2024 · 144 citations

Pharmacy, Cardiology, Pharmacotherapy +14